These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

567 related articles for article (PubMed ID: 23476052)

  • 1. Idiosyncratic adverse drug reactions: current concepts.
    Uetrecht J; Naisbitt DJ
    Pharmacol Rev; 2013 Apr; 65(2):779-808. PubMed ID: 23476052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How Reactive Metabolites Induce an Immune Response That Sometimes Leads to an Idiosyncratic Drug Reaction.
    Cho T; Uetrecht J
    Chem Res Toxicol; 2017 Jan; 30(1):295-314. PubMed ID: 27775332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Idiosyncratic Drug Reactions: A 35-Year
    Uetrecht J
    Chem Res Toxicol; 2022 Oct; 35(10):1649-1654. PubMed ID: 35687011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of the immune system in idiosyncratic drug reactions.
    Zhang X; Liu F; Chen X; Zhu X; Uetrecht J
    Drug Metab Pharmacokinet; 2011; 26(1):47-59. PubMed ID: 21084762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Emerging Role of the Innate Immune Response in Idiosyncratic Drug Reactions.
    Sernoskie SC; Jee A; Uetrecht JP
    Pharmacol Rev; 2021 Jul; 73(3):861-896. PubMed ID: 34016669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Idiosyncratic drug reactions: past, present, and future.
    Uetrecht J
    Chem Res Toxicol; 2008 Jan; 21(1):84-92. PubMed ID: 18052104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune-mediated adverse drug reactions.
    Uetrecht J
    Chem Res Toxicol; 2009 Jan; 22(1):24-34. PubMed ID: 19149477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Animal models of idiosyncratic drug reactions.
    Ng W; Lobach AR; Zhu X; Chen X; Liu F; Metushi IG; Sharma A; Li J; Cai P; Ip J; Novalen M; Popovic M; Zhang X; Tanino T; Nakagawa T; Li Y; Uetrecht J
    Adv Pharmacol; 2012; 63():81-135. PubMed ID: 22776640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current understanding of the mechanisms of idiosyncratic drug-induced agranulocytosis.
    Johnston A; Uetrecht J
    Expert Opin Drug Metab Toxicol; 2015 Feb; 11(2):243-57. PubMed ID: 25424130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug Hypersensitivity: How Drugs Stimulate T Cells via Pharmacological Interaction with Immune Receptors.
    Pichler WJ; Adam J; Watkins S; Wuillemin N; Yun J; Yerly D
    Int Arch Allergy Immunol; 2015; 168(1):13-24. PubMed ID: 26524432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of inflammasomes by agents causing idiosyncratic skin reactions: a possible biomarker.
    Weston JK; Uetrecht J
    Chem Res Toxicol; 2014 Jun; 27(6):949-51. PubMed ID: 24877608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune mechanisms of idiosyncratic drug-induced liver injury.
    Mak A; Uetrecht J
    J Clin Transl Res; 2017 Feb; 3(1):145-156. PubMed ID: 30873473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The danger hypothesis applied to idiosyncratic drug reactions.
    Li J; Uetrecht JP
    Handb Exp Pharmacol; 2010; (196):493-509. PubMed ID: 20020274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A transgenic mouse model for HLA-B*57:01-linked abacavir drug tolerance and reactivity.
    Cardone M; Garcia K; Tilahun ME; Boyd LF; Gebreyohannes S; Yano M; Roderiquez G; Akue AD; Juengst L; Mattson E; Ananthula S; Natarajan K; Puig M; Margulies DH; Norcross MA
    J Clin Invest; 2018 Jul; 128(7):2819-2832. PubMed ID: 29782330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigations toward enhanced understanding of hepatic idiosyncratic drug reactions.
    Liguori MJ; Waring JF
    Expert Opin Drug Metab Toxicol; 2006 Dec; 2(6):835-46. PubMed ID: 17125404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire.
    Ostrov DA; Grant BJ; Pompeu YA; Sidney J; Harndahl M; Southwood S; Oseroff C; Lu S; Jakoncic J; de Oliveira CA; Yang L; Mei H; Shi L; Shabanowitz J; English AM; Wriston A; Lucas A; Phillips E; Mallal S; Grey HM; Sette A; Hunt DF; Buus S; Peters B
    Proc Natl Acad Sci U S A; 2012 Jun; 109(25):9959-64. PubMed ID: 22645359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of HLA-B Allelic Variation and IFN-γ ELISpot Responses in Patients with Severe Cutaneous Adverse Reactions Associated with Drugs.
    Klaewsongkram J; Sukasem C; Thantiworasit P; Suthumchai N; Rerknimitr P; Tuchinda P; Chularojanamontri L; Srinoulprasert Y; Rerkpattanapipat T; Chanprapaph K; Disphanurat W; Chakkavittumrong P; Tovanabutra N; Srisuttiyakorn C;
    J Allergy Clin Immunol Pract; 2019 Jan; 7(1):219-227.e4. PubMed ID: 29800753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Idiosyncratic drug reactions: current understanding.
    Uetrecht J
    Annu Rev Pharmacol Toxicol; 2007; 47():513-39. PubMed ID: 16879083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NEW STRATEGIES TO PREDICT AND PREVENT SERIOUS IMMUNOLOGICALLY MEDIATED ADVERSE DRUG REACTIONS.
    Phillips EJ
    Trans Am Clin Climatol Assoc; 2018; 129():74-87. PubMed ID: 30166701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLADR: a database system for enhancing the discovery of biomarkers for predicting human leukocyte antigen-mediated idiosyncratic adverse drug reactions.
    Du T; Yang L; Luo H; Zhou P; Mei H; Xuan J; Xing Q; Ning B; Mendrick DL; Shi L
    Biomark Med; 2015; 9(11):1079-93. PubMed ID: 26501190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.